Science Current Events | Science News | Brightsurf.com
 

Recent Hiv Positive Current Events | Hiv Positive News

Page 1 of 40 | 988 Results
Previous0102030405060708091011   Next   
Sort By: Relevance | Page Views
Selenium may slow march of AIDS
Increasing the production of naturally occurring proteins that contain selenium in human blood cells slows down multiplication of the AIDS virus, according to biochemists.   view more (2008-12-01)

ACP recommends routine HIV screening for all patients
On World AIDS Day, the American College of Physicians (ACP) is giving doctors a call-to-action to routinely encourage HIV screening to all of their patients older than 13 years. This new practice guideline appears on the Annals of Internal Medicine Web site at www.annals.org.   view more (2008-12-01)

Nature Medicine study shows Peregrine's bavituximab can cure lethal virus infections
Peregrine Pharmaceuticals, Inc. (NASDAQ: PPHM) today reported publication of data in Nature Medicine that supports the broad anti-viral potential of the company's novel anti-phosphatidylserine (anti-PS) antibody platform, showing that its PS-targeting drug bavituximab can cure lethal virus... view more (2008-11-24)

Landmark study defines benefits of early HIV testing and treatment for infected infants
Testing very young babies for HIV and giving antiretroviral therapy (ART) immediately to those found infected with the virus dramatically prevents illness and death, according to a report in the New England Journal of Medicine.   view more (2008-11-20)

Uncertainty Can Be More Stressful Than Clear Negative Feedback
We are faced with uncertainty every day. Will our investments pay off? Will we get the promotions we are hoping for? When faced with the unknown, most people experience some degree of anxiety and discomfort.   view more (2008-11-20)

First Holistic Guide to Primate Disease Covers Critical Gap in Global Health
Why are so many infectious diseases jumping from animals to humans? Why do we have so little capacity to predict epidemics, or avoid them?   view more (2008-11-19)

Study finds Canada's supervised injection facility cost-effective
Canada's only supervised injection facility is extending lives and saving the health-care system millions of dollars, a new study shows.   view more (2008-11-18)

Results of landmark study of HIV vaccine published in the Lancet
Results from the Step study, a test-of-concept efficacy study of a Merck & Co., Inc. HIV vaccine candidate, were published online today in two papers in The Lancet. These analyses of the Step study are being conducted, presented and published to inform the continued search for an effective HIV... view more (2008-11-13)

Researchers describe how cells take out the trash to prevent disease
Garbage collectors are important for removing trash; without them waste accumulates and can quickly become a health hazard. Similarly, individual cells that make up such biological organisms as humans also have sophisticated methods for managing waste.   view more (2008-11-11)

Researchers use chemical from medicinal plants to fight HIV
Like other kinds of cells, immune cells lose the ability to divide as they age because a part of their chromosomes known as a telomere becomes progressively shorter with cell division. As a result, the cell changes in many ways, and its disease fighting ability is compromised.   view more (2008-11-10)

Engineered killer T cell recognizes HIV-1's lethal molecular disguises
Researchers at the University of Pennsylvania School of Medicine and colleagues in the United Kingdom have engineered T cells able to recognize HIV-1 strains that have evaded the immune system.   view more (2008-11-10)

T cell-based HIV vaccine candidate demonstrates positive results
The question of whether or not to continue to pursue the development of T-cell-based HIV-1 vaccines has been a source of controversy following last year's widely publicized failure of the field's most promising candidate, a vaccine developed by Merck known as V520.   view more (2008-11-10)

Protein identified that turns off HIV-fighting T cells
In HIV-infected patients the body's immune system is unable to fight off the virus. A new study to be published online on November 10th in the Journal of Experimental Medicine shows that T cells in HIV-infected individuals express a protein called TIM-3, which inactivates their virus killing... view more (2008-11-10)

DNA chunks, chimps and humans
Researchers have carried out the largest study of differences between human and chimpanzee genomes, identifying regions that have been duplicated or lost during evolution of the two lineages.   view more (2008-11-06)

New HIV-reduction initiative takes to the fields
Education has found its way onto the soccer fields of North Carolina - in the form of a social experiment that may have all the right ingredients to change the direction of Latino health in the United States.   view more (2008-11-06)

Minority patients discouraged from cancer screening by negative messages
New behavioral science research published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research, found that constantly emphasizing the negative consequences of a lack of cancer screening among minorities can actually make them less likely to... view more (2008-11-06)

XDR-TB: Deadlier and more mysterious than ever
New research has found that XDR-TB is increasingly common and more deadly than previously known. Extensively drug-resistant tuberculosis (XDR-TB) is a growing public health threat that is only just beginning to be understood by medical and public health officials.   view more (2008-11-06)

Extended-treatment with combination medication for opioid-addicted youths shows benefit
Adolescents addicted to opioids who received continuing treatment with the combination medication buprenorphine-naloxone had lower rates of testing positive or reporting use of opioids compared to youths who went through a short-term detoxification program using the same medication, according to a... view more (2008-11-05)

Tibotec presents interim findings for TMC435, an investigational genotype 1 hepatitis C treatment
New clinical data show antiviral activity of TMC435, an investigational protease inhibitor (PI) being developed by Tibotec BVBA for the treatment of chronic hepatitis C virus (HCV) infection.   view more (2008-11-04)

Study finds fears of HIV transmission in families with infected parent
Despite ongoing efforts to educate the public about HIV, a new study by researchers from UCLA, the RAND Corp., Harvard University and Children's Hospital Boston has found that two-thirds of families with an HIV-infected parent experience fears about spreading HIV in the home.   view more (2008-11-04)

New evidence for homeopathy
Two new studies conclude that a review which claimed that homeopathy is just a placebo, published in The Lancet, was seriously flawed.    view more (2008-11-04)

Study reports Double Balloon Endoscopy useful for diagnosis and treatment of obscure GI bleeding
A study by researchers in Japan concludes that Double Balloon Endoscopy (DBE) was very useful in the diagnosis of obscure gastrointestinal (GI) bleeding and had a therapeutic impact on the majority of patients.   view more (2008-11-03)

Parents comfortable with alcohol screening in pediatricians' offices
Parents are surprisingly receptive to being screened for alcohol problems during a visit to their child's pediatrician, including those who have alcohol problems. And if they need help, many parents would look to their pediatrician for a referral, according to a new study in the November issue of... view more (2008-11-03)

How HIV vaccine might have increased odds of infection
In September 2007, a phase II HIV-1 vaccine trial was abruptly halted when researchers found that the vaccine may have promoted, rather than prevented, HIV infection.   view more (2008-11-03)

UC Davis researchers discover a key to aggressive breast cancer
In trying to find out why HER2-positive breast cancer can be more aggressive than other forms of the disease, UC Davis Cancer Center researchers have surprisingly discovered that HER2 itself is the culprit. By shutting down its own regulator gene, HER2 creates a permissive environment for tumor... view more (2008-10-31)
Page 1 of 40 | 988 Results
Previous0102030405060708091011   Next   
Sort By: Relevance | Page Views
© 2008 BrightSurf.com